Biodistribution and anti-tumor activities of the131I-labeled rituximab in nude mice bearing human Burkitt’s lymphoma
✍ Scribed by Qiang Zuo; Aimin Li; Xiao Yan; Rongcheng Luo
- Publisher
- Springer-Verlag
- Year
- 2009
- Weight
- 434 KB
- Volume
- 6
- Category
- Article
- ISSN
- 1674-5361
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Background: Some vasoactive drugs have been studied in the hope of altering the vascular permeability and/or blood of tumors to enhance monoclonal antibody (moab) uptake. the pretreatment of interleukin-2 (il-2), one of the vasoactive reagents, produced a generalized vascular permeability, but i
A new anti-CD24 immunotoxin (IT), SWAl l.dgA, was constructed by coupling the MAb SWAl I via the bivalent linker SMPT to deglycosylated r i c h A-chain (dgA). The effects of SWAl I .dgA were evaluated in vitro against the B-precursor leukemia cell line REH, the non-6-non-T acute lymphoblastic leukem